← Open Payments lookup

MICHAEL ZAFRANI: Open Payments

NPI 1982780128 · AICA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,485 in 190 payments from 11 companies in 2025. Trend: 2023 $5,398 · 2024 $4,372 · 2025 $5,485

Food & beverage: $5,391Education: $94
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.32$1,510
Neurocrine BioSciences, Inc.34$858
ABBVIE INC.31$816
Otsuka America Pharmaceutical, Inc.21$583
Lundbeck LLC17$473
E.R. Squibb & Sons, L.L.C.16$424
Vanda Pharmaceuticals Inc.14$262
Janssen Pharmaceuticals, Inc9$224
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$182
Axsome Therapeutics, Inc.5$126

Products named: UZEDY, INGREZZA, VRAYLAR, REXULTI, AUSTEDO XR, COBENFY, ABILIFY MAINTENA, FANAPT.

Industry payments across HI — which companies pay providers there.